Citigroup
SCR

Citigroup’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Citigroup’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-48
Closed – – 7494
2013
Q4 		$0 Buy
+48
New +$456 ﹤0.01% 7355
2013
Q3 		– Sell
-29
Closed – – 7224
2013
Q2 		$0 Buy
+29
New +$268 ﹤0.01% 6886

Citigroup's SCR Position: Q1 2014 in Review

Citigroup sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 48 shares.

Citigroup first reported a position in SCR in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Citigroup reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Citigroup sold 48 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014.
  • Citigroup first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 2 quarters.
  • Citigroup's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $0 in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Citigroup's 13F filing for Q1 2014, filed 15 May 2014.